CD19 and neoplasm: In this study, T-cell migration to the target tumor was not observed on PET images, unlike in the reports by Sato et al. and Weist et al. It was disappointing to observe that only a minority of intravenously administered CAR T-cells migrated to tumor deposits, even though we used CD19 CAR T-cells with proven efficacy in animals and humans.